Expert Interview
Discussing the potential of Gazyva (obinutuzumab) for the treatment of lupus nephritis ahead of the PDUFA
Ticker(s): RHHBYInstitution: Singing River Health System
- Board certified Rheumatologist in clinical practice for 18+ years.
- Manages 1200 RA patients, 450 PsA patients, and 45-50 scleroderma patients in a non-academic community hospital system.
How many lupus patients do you treat?
Added By: wilson_adminHow are lupus patients currently managed?
Added By: wilson_adminHow strong is the REGENCY data in your opinion?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
